HARVARD MANAGEMENT CO INC - NEON THERAPEUTICS INC ownership

Quarter-by-quarter ownership
HARVARD MANAGEMENT CO INC ownership history of NEON THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$1,335,000
+123.6%
505,8710.0%0.21%
+231.7%
Q4 2019$597,000
-31.4%
505,8710.0%0.06%
-22.2%
Q3 2019$870,000
-63.7%
505,8710.0%0.08%
-86.3%
Q2 2019$2,398,000
-26.6%
505,8710.0%0.59%
-28.6%
Q1 2019$3,268,000
+28.4%
505,8710.0%0.83%
+54.7%
Q4 2018$2,545,000
-41.1%
505,8710.0%0.54%
-51.4%
Q3 2018$4,320,000
-32.2%
505,8710.0%1.10%
-27.1%
Q2 2018$6,374,000505,8711.51%
Other shareholders
NEON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 9,741,636$16,756,0009.49%
MYDA Advisors LLC 155,000$267,0000.12%
Endurant Capital Management LP 193,052$332,0000.12%
FNY Investment Advisers, LLC 210,000$361,0000.11%
HARVARD MANAGEMENT CO INC 505,871$870,0000.08%
Alambic Investment Management, L.P. 25,800$44,0000.03%
OXFORD ASSET MANAGEMENT LLP 209,307$360,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 155,619$268,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 116,600$201,0000.00%
Tower Research Capital LLC (TRC) 14,371$25,0000.00%
View complete list of NEON THERAPEUTICS INC shareholders